Breaking News

You are here » Indian-Commodity  :  Top News  :  Adani Power's arm to produce additional 1,600 MW of power by 2020: Report


Adani Power's arm to produce additional 1,600 MW of power by 2020: Report

Adani Power's subsidiary - Udupi Power Corporation (UPCL), will reportedly produce an additional 1,600 MW of power at its thermal plant in Udupi by 2020. At present, the plant produces 1200 MW of power. The company has signed a memorandum of understanding with the Karnataka Government to set up 2X800 MW coal-based power plant in Udupi with an investment of Rs 11,500 crore, in its second phase expansion.

At present, the company has two units of 600 MW each spread across 590 acres in Yellur and Santhuru villages of Udupi district. Set up at a cost of Rs 6,000 crore, the commercial production from the unit-1 began in 2010 and unit-2 in 2012.

Adani Power is engaged in the business of generation, accumulation, distribution and supply of power and to generally deal in electricity and to explore, develop, generate, accumulate, supply and distribute or to deal in other forms of energy from any source whatsoever.

Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......